Emma Wilmot is an associate professor at the University of Nottingham with an honorary role as Consultant Diabetologist at Derby Teaching Hospitals NHS Foundation Trust. She qualified from the University of Glasgow and completed a PhD on type 2 diabetes in younger adults and sedentary behaviour at the University of Leicester, under the supervision of Professors Melanie Davies and Kamlesh Khunti.

Dr Wilmot specialises in insulin pump therapy, antenatal diabetes and young adult diabetes in addition to integrated community diabetes care. She has an active interest in diabetes research and is a principal investigator on diabetes research trials. She was awarded the University of Leicester College of Medicine, Biological Sciences and Psychology prize for excellent PhD performance.

She is the founder of the ABCD Diabetes Technology Network (www.dtn-uk.care), which aims to improve access to diabetes technologies for people with diabetes. As Chair, she previously led the delivery of educational events for multidisciplinary diabetes teams and the development of a suite of national diabetes technology best-practice guides, in addition to online modules for people living with diabetes.

She is an executive board member for the UK structured education programme for type 1 diabetes ‘Dose Adjustment for Normal Eating’ (DAFNE), an elected member of the ABCD committee and an invited speaker at a range of national and international diabetes meetings. She is also a member of the National Diabetes Audit Insulin Pump Expert Reference Group and has been involved in the #languagematters movement.

Duality of Interest: Dr Wilmot has received speaker’s fees/honoraria from Abbott, Dexcom, Eli Lilly & Company, Insulet, Sanofi and Novo Nordisk. She has also received payments for membership of boards/advisory panels from Abbott, Dexcom, Eli Lilly & Company, Insulet and Sanofi together with payments for other education activities from Novo Nordisk.

Date: Winter 2022